GB201103283D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number: GB201103283D0
Authority: GB; United Kingdom
Prior art keywords: novel compounds; novel; compounds
Prior art date: 2011-02-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

GBGB1103283.6A

Other versions

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Prosidion Ltd

Original Assignee

Prosidion Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-02-25

Filing date

2011-02-25

Publication date

2011-04-13

2011-02-25 Application filed by Prosidion Ltd filed Critical Prosidion Ltd

2011-02-25 Priority to GB1103283.6A priority Critical patent/GB2488360A/en

2011-04-13 Publication of GB201103283D0 publication Critical patent/GB201103283D0/en

2011-05-24 Priority to TW100118140A priority patent/TW201209054A/en

2011-05-27 Priority to PCT/EP2011/058703 priority patent/WO2011147951A1/en

2011-05-27 Priority to ARP110101820A priority patent/AR081252A1/en

2012-08-29 Publication of GB2488360A publication Critical patent/GB2488360A/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

GB1103283.6A 2010-05-28 2011-02-25 Heterocyclic GPCR agonists Withdrawn GB2488360A (en)

Priority Applications (4)

Application Number	Priority Date	Filing Date	Title
GB1103283.6A GB2488360A (en)	2011-02-25	2011-02-25	Heterocyclic GPCR agonists
TW100118140A TW201209054A (en)	2010-05-28	2011-05-24	Novel compounds
PCT/EP2011/058703 WO2011147951A1 (en)	2010-05-28	2011-05-27	Cycloamino derivatives as gpr119 antagonists
ARP110101820A AR081252A1 (en)	2010-05-28	2011-05-27	COMPOUNDS FOR THE TREATMENT OF METABOLIC SYNDROME

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB1103283.6A GB2488360A (en)	2011-02-25	2011-02-25	Heterocyclic GPCR agonists

Publications (2)

Publication Number	Publication Date
GB201103283D0 true GB201103283D0 (en)	2011-04-13
GB2488360A GB2488360A (en)	2012-08-29

Family

ID=43904202

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB1103283.6A Withdrawn GB2488360A (en)	2010-05-28	2011-02-25	Heterocyclic GPCR agonists

Country Status (1)

Country	Link
GB (1)	GB2488360A (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7638541B2 (en) *	2006-12-28	2009-12-29	Metabolex Inc.	5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
EP2114936A1 (en) *	2007-01-04	2009-11-11	Prosidion Limited	Piperidine gpcr agonists
JP5489997B2 (en) *	2007-07-19	2014-05-14	シマベイセラピューティクス，インコーポレーテッド	N-aza cyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of RUP3 or GPRl 19 receptors for the treatment of diabetes and metabolic diseases
PL2280704T3 (en) *	2008-03-31	2015-10-30	Cymabay Therapeutics Inc	Oxymethylene aryl compounds and uses thereof
GB0812648D0 (en) *	2008-07-10	2008-08-20	Prosidion Ltd	Compounds
EP2331503B1 (en) *	2008-07-11	2013-08-21	Irm Llc	4-phenoxymethylpiperidines as modulators of gpr119 activity
GB0904287D0 (en) *	2009-03-12	2009-04-22	Prosidion Ltd	Compounds for the treatment of metabolic disorders

2011
- 2011-02-25 GB GB1103283.6A patent/GB2488360A/en not_active Withdrawn

Also Published As

Publication number	Publication date
GB2488360A (en)	2012-08-29

Legal Events

Date	Code	Title	Description
2013-07-17	WAP	Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)

Publication	Publication Date	Title
GB201114103D0 (en)	2011-09-28	Novel compounds
GB201106799D0 (en)	2011-06-01	Novel compounds
GB201107325D0 (en)	2011-06-15	Novel compounds
GB201116641D0 (en)	2011-11-09	Novel compounds
GB201109763D0 (en)	2011-07-27	Compounds
GB201106395D0 (en)	2011-06-01	Compounds
GB201112607D0 (en)	2011-09-07	Novel compounds
GB201107197D0 (en)	2011-06-15	Compounds
GB201111704D0 (en)	2011-08-24	Novel compounds
EP2717694A4 (en)	2014-11-12	Novel compounds
GB201122113D0 (en)	2012-02-01	Novel compounds
GB201110938D0 (en)	2011-08-10	Compounds
GB201105659D0 (en)	2011-05-18	Compounds
GB201121357D0 (en)	2012-01-25	Novel compounds
GB201121358D0 (en)	2012-01-25	Novel compounds
GB201121360D0 (en)	2012-01-25	Novel compounds
GB201118658D0 (en)	2011-12-07	Novel compounds
GB201115321D0 (en)	2011-10-19	Novel compounds
GB201115319D0 (en)	2011-10-19	Novel compounds
GB201114399D0 (en)	2011-10-05	Novel compounds
GB201113757D0 (en)	2011-09-21	Novel compounds
GB201113761D0 (en)	2011-09-21	Novel compounds
GB201113764D0 (en)	2011-09-21	Novel compounds
GB201113766D0 (en)	2011-09-21	Novel compounds
GB201111410D0 (en)	2011-08-17	Novel compounds